VJHemOnc is committed to improving our service to you

ASH 2018 | MPN updates: personalized prognostication, novel treatments & more

VJHemOnc is committed to improving our service to you

Ruben Mesa

Ruben Mesa, MD, of the UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX, shares his view on the highlights for myeloproliferative neoplasms (MPNs), including novel treatments, outlooks, and individualized prognostication, from the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter